Part Details | FUROSEMIDE INJECTION
6505-01-157-5116
Alternate Parts: NDC00186111413, NDC00186-1114-13, NDC00641038224, NDC00641-0382-24, NDC00517570201, NDC00517-5702-01, NDC00469750010, NDC00469-7500-10, 6505-01-157-5116, 01-157-5116, 6505011575116, 011575116
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JUL 07, 1983 | 01-157-5116 | 30041 ( FUROSEMIDE INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-157-5116
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00186-1114-13 | 04473 | ASTRA PHARMACEUTICALS LP |
| NDC00641-0382-24 | 51968 | ELKINS-SINN INC |
| NDC00517-5702-01 | 32288 | LUITPOLD PHARMACEUTICALS INCDBA OSTEOHEALTH COMPANY |
| NDC00469-7500-10 | 60567 | LYPHOMED INCDIV OF FUJISAWA USA INC |
Technical Data | NSN 6505-01-157-5116
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY10.000 MILLIGRAMS FUROSEMIDE |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |